Evidence map›Paper›PMID 41426942›Full record

ArticleCureus2025

First Radiologic Description of CIC-FOXO4 Sarcoma: A Case Report of a Rare and Aggressive Sarcoma and Review of the Literature.

Ayoub Nahal

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ayoub NahalPathology and Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, ARE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CIC-rearranged sarcomas are a recently recognized subset of undifferentiated round cell sarcomas, distinct from Ewing sarcoma in both clinical behavior and molecular profile. While CIC-DUX4 is the most described fusion, CIC-FOXO4 is exceedingly rare, with only a handful of reported cases. We report a 47-year-old male with a 3.6 cm intramuscular mass in the left lateral abdominal wall. Molecular testing confirmed a CIC-FOXO4 sarcoma. The lesion was surgically excised and showed predominant epithelioid morphology within a desmoplastic fibrous stroma. The patient is alive with disease, developing three metastatic pulmonary nodules six months after initial presentation, for which he received adjuvant chemotherapy. To our knowledge, this represents the sixth reported case of CIC-FOXO4 sarcoma in the English literature and the first with radiologic description. This case adds to the limited radiologic literature on this rare entity and emphasizes the importance of including CIC-rearranged sarcoma in the differential diagnosis of atypical soft tissue masses.

Indexed as

cic-foxo4 sarcomacic-rearranged sarcomaepithelioid histologyfusion sarcomamolecular diagnosis

Identifiers

PMID41426942
PMCPMC12717871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.